Three Healthcare Stocks with Questionable Fundamentals

Industry
โดย Yahoo Finance·Read original
Summary · why it matters

Three healthcare stocks may face trouble due to weak fundamentals. Danaher has seen no organic revenue growth over the past two years, its operating margin fell by 10.6 percentage points over five years, and earnings per share were flat. Solventum's organic revenue growth fell short of benchmarks, sales are projected to be flat over the next 12 months, and its free cash flow margin dropped by 30.8 percentage points over five years. agilon health experienced underwhelming customer growth, flat revenue is expected over the next 12 months, and the company has cash-burning tendencies.

Impact on stocks 3

Aging Population▼ · 2 stocks
agilon health Inc
AGL
▼ NegativeDemandrelevance

Underwhelming customer growth and flat revenue expected over next 12 months.

Solventum Corp.
SOLV
▼ NegativeCapitalrelevance

Organic revenue growth fell short, sales projected flat, free cash flow margin dropped 30.8pp.

Biotech & Genomic Medicine▼ · 1 stocks
Danaher Corporation
DHR
▼ NegativeCapitalrelevance

No organic revenue growth over two years, operating margin fell 10.6pp, EPS flat.

© 2026 MarketDXNews